v3.26.1
Note 12 - Segment Information - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
General and administrative expense $ 7,403   $ 4,651   $ 14,310 $ 9,556
Other income 1,825   1,185   3,807 2,518
Net loss (25,154) $ (18,317) (19,881) $ (16,633) (43,471) (36,514)
Single Reportable Segment [Member]            
Research and development expense 19,576   16,415   32,968 29,476
General and administrative expense 7,403   4,651   14,310 9,556
Other income 1,825   1,185   3,807 2,518
Net loss (25,154)   (19,881)   (43,471) (36,514)
Personnel [Member] | Single Reportable Segment [Member]            
Research and development expense 4,682   2,417   9,274 5,187
General and administrative expense 4,540   3,102   9,454 6,404
General [Member] | Single Reportable Segment [Member]            
Research and development expense 1,632   1,709   2,969 3,358
General and administrative expense 2,863   1,549   4,856 3,152
Tovecimig [Member] | Single Reportable Segment [Member]            
Research and development expense 10,314   7,749   15,290 14,426
CTX-471 [Member] | Single Reportable Segment [Member]            
Research and development expense 887   1,760   1,745 2,459
CTX-8371 [Member] | Single Reportable Segment [Member]            
Research and development expense 1,224   1,044   2,008 1,573
CTX-10726 [Member] | Single Reportable Segment [Member]            
Research and development expense $ 837   $ 1,736   $ 1,682 $ 2,473